Ultrasound guided external oblique intercostal plane block versus posterior transversus abdominis plane block for postoperative analgesia in adult patients undergoing open nephrectomy: a randomized trial

Résumé

BACKGROUND: Nephrectomy procedures result in considerable postoperative discomfort, and limitations on the use of traditional management include opioid-related adverse effects and epidural-associated side effects. A prospective comparison was conducted to evaluate the relative effectiveness of two regional anesthetic techniques, the external oblique intercostal plane block (EOIPB) and the ultrasound-guided posterior transversus abdominis plane block (TAPB), in reducing postsurgical pain after open nephrectomy (OPN). METHODS: Forty adults who underwent elective OPN were included in the study. The study population was randomly divided into two groups to receive either EOIPB or TAPB in a volume of 20 mL with 0.5% bupivacaine after the induction phase. The primary outcome was cumulative 24-hour pethidine consumption. Secondary outcomes included intraoperative fentanyl requirements, time to first rescue analgesia, pain scores at 0, 4, 8, 12, 18, and 24 h postoperatively, hemodynamic parameters, adverse events, and patient satisfaction. RESULTS: The EOIPB group had significantly lower pain scores at 4, 8, 12, and 18 h after surgery compared to the TAPB group (p < 0.05). The EOIPB group used significantly less pethidine than the other group (61.5 ± 24.77 mg vs. 114 ± 12.31 mg, p < 0.001), and it took them longer to receive their first rescue analgesia (7.25 ± 0.91 vs. 6.1 ± 1.55 h, p = 0.007). The EOIPB group exhibited significantly higher patient satisfaction (p = 0.045), although the two groups had similar profiles of adverse events. CONCLUSIONS: In adults undergoing OPN, EOIPB provided superior early postoperative analgesia compared to TAPB during the first 18 h after surgery, as evidenced by lower pain scores, reduced opioid requirements, delayed time first to rescue analgesia, and higher patient satisfaction. Both blocks demonstrated comparable safety profiles. CLINICAL TRIAL: Registration occurring at ClinicalTrials.gov (ID: NCT06452238), (URL: https://clinicaltrials.gov/study/NCT06452238?cond=NCT06452238&rank=1 ), Date: (30-5-2024).

Citer ce document

Accès au document

Texte intégral en lecture en ligne, réservé aux abonnés SPHAERO et aux membres de l'institution. Se connecter

Auteur(s)

Statistiques

Consultations : 1

Téléchargements : 0